Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amedisys Inc
(NQ:
AMED
)
98.35
-0.10 (-0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amedisys Inc
< Previous
1
2
3
4
Next >
Preview: Amedisys's Earnings
October 25, 2022
Amedisys (NASDAQ:AMED) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Amedisys will...
Via
Benzinga
Expert Ratings for Amedisys
October 24, 2022
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Where Amedisys Stands With Analysts
October 24, 2022
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter:
Via
Benzinga
University of Arkansas for Medical Sciences (UAMS) Announces a Partnership with Amedisys and Contessa, Creating a Comprehensive Care at Home Suite of Services
October 11, 2022
From
Amedisys, Inc.
Via
GlobeNewswire
6 Analysts Have This to Say About Amedisys
October 03, 2022
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
August 02, 2022
Upgrades
Via
Benzinga
What 9 Analyst Ratings Have To Say About Amedisys
July 28, 2022
Over the past 3 months, 9 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Recap: Amedisys Q2 Earnings
July 27, 2022
Amedisys (NASDAQ:AMED) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amedisys beat estimated earnings by...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022
June 29, 2022
Upgrades
Via
Benzinga
Analyst Ratings for Amedisys
June 21, 2022
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter:
Via
Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
Via
Benzinga
Stephens & Co. Maintains Equal-Weight Rating for Amedisys: Here's What You Need To Know
June 21, 2022
Stephens & Co. has decided to maintain its Equal-Weight rating of Amedisys (NASDAQ:AMED) and lower its price target from $155.00 to $125.00. Shares of Amedisys are trading down 12.59% over the last 24...
Via
Benzinga
7 Analysts Have This to Say About Amedisys
April 29, 2022
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter:
Via
Benzinga
Analyst Ratings For Amedisys
November 08, 2021
Over the past 3 months, 11 analysts have published their opinion on Amedisys (NASDAQ:
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
June 21, 2022
Goldman Sachs cut SunPower Corporation. (NASDAQ: SPWR) price target from $19 to $13. SunPower shares fell 3.1% to $17.37 in pre-market trading.
Via
Benzinga
Analyst Ratings for Amedisys
May 27, 2022
Over the past 3 months, 5 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
March 01, 2022
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,...
Via
Benzinga
Where Amedisys Stands With Analysts
February 25, 2022
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
February 25, 2022
Upgrades According to 86 Research, the prior rating for NetEase Inc (NASDAQ:NTES) was changed from Hold to Buy. For the fourth quarter, NetEase had an EPS of $1.56,...
Via
Benzinga
Amedisys: Q4 Earnings Insights
February 23, 2022
Amedisys (NASDAQ:AMED) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The U.S. Home Health Care Industry Is Reportedly Booming As Seniors Overwhelmingly Want To Live At Home
February 07, 2022
Photo by Kampus Production from Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice...
Via
Benzinga
This Company Just Made a Possibly Lucrative Acquisition — What's Next?
January 14, 2022
Photo by Ccfb on Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The global...
Via
Benzinga
10 Bargain Stocks to Buy After Falling 30% in 2021
December 20, 2021
If you’re looking for bargain stocks to buy that are down 30% or more in 2021, that’s not an easy task. Here are 10 that fit the bill.
Via
InvestorPlace
This Home Medical Company Looks to Be Moving Fast — What's Next?
December 10, 2021
Photo by National Cancer Institute on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a...
Via
Benzinga
Best Undervalued Health Care Companies You Never Heard Of
November 25, 2021
Health care is a gigantic industry and global spending is expected to rise at a 3.9% compound annual growth rate by 2024. Here are three health care stocks that look interesting.
Via
Talk Markets
This Industry, Important for Quality of Life, Is Big Business
November 15, 2021
Photo by Hush Naidoo Jade Photography on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a...
Via
Benzinga
Global Home Medical Equipment Market Size Is Estimated To Reach $56 Billion By 2027
November 09, 2021
Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – Over the last few years, and with the ‘help’ of the pandemic, home health care medical equipment industry has surged. Home...
Via
FinancialNewsMedia
What 12 Analyst Ratings Have To Say About Amedisys
November 04, 2021
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within t...
Via
Benzinga
Amedisys, inc (AMED) Q3 2021 Earnings Call Transcript
November 03, 2021
AMED earnings call for the period ending October 2, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.